Anticancer agent 118, a N‑acylated ciprofloxacin derivative, has anti- bacterial and anticancer activities. Anticancer agent 118 shows high activity against Gram-positive strains and antiproliferative activities against prostate PC3 cells. Anticancer agent 118 can be used for antitumor research.